Metacognitive therapy for body dysmorphic disorder patients in Iran: Acceptability and proof of concept

M. Rabiei, S. Mulkens, M. Kalantari, H. Molavi, F. Bahrami

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The purpose of the present study was to determine the effect of metacognitive therapy (MCT) on symptoms of body dysmorphic disorder (BDD) and on symptoms of thought-fusion, by means of a wait-list controlled clinical trial. Participants were referred from dermatology and cosmetic surgery clinics in the city of Isfahan, Iran, and 20 patients were selected on the basis of DSM-IV-TR diagnostic criteria for BOO. They were randomly assigned to either the experimental or the wait-list control group. The Yale-Brown Obsessive Compulsive Scale Modified for Body Dysmorphic Disorder (BDD-YBOCS) and the Thought-Fusion Inventory (TFI) were used as the outcome measures. The experimental group received 8 weekly metacognitive intervention sessions. The control group was in the waiting-list until the end of the follow-up. Measures were taken at pre-test, post-test (after 2 months) and follow-up (after 6-months), The results of analysis of variance showed that MCT significantly reduced the symptoms of BDD and of thought-fusion, compared to the wait-list. Effects on both outcome measures were maintained at 6-months follow-up. 

Original languageEnglish
Pages (from-to)724-729
Number of pages6
JournalJournal of Behavior Therapy and Experimental Psychiatry
Volume43
Issue number2
DOIs
Publication statusPublished - Jun 2012

Keywords

  • Body dysmorphic disorder
  • Metacognitive therapy
  • Obsessive-compulsive disorder
  • Thought-fusion
  • OBSESSIVE-COMPULSIVE DISORDER
  • CONTROLLED-TRIAL
  • PREVALENCE
  • MODEL
  • RESPONSIBILITY
  • SYMPTOMS

Cite this